Affiliation:
1. Niğde Ömer Halisdemir Eğitim Araştırma Hastanesi
2. University of Health Sciences, Ankara Atatürk Sanatorium Training and Research Hospital.
Abstract
Introduction: Jaundice is one of the most common problems at neonatal period and seen in 60-70% of all newborns at first days of life. Prolonged jaundice is defined as hyperbilirubinemia persisting at the end of week 2 in term newborns.
In this study, we reviewed term newborns diagnosed with prolonged jaundice. It was aimed to demonstrate delaying laboratory evaluations for a week in infants with favorable clinical presentation can prevent unnecessary tests in majority of newborns.
Materials and methods: The study included full-term newborns who presented after day 14 of life and diagnosed with prolonged jaundice at neonatology outpatient clinic of Health Sciences University, Keçiören Teaching and Research Hospital in 2016. Overall, 336 infants with prolonged jaundice were screened. The infants with congenital anomaly, those with findings of sepsis or severe infection, those with history of intrauterine infection, those with history of acholic stool and those with no available data were excluded. In 180 patients included, clinical evaluations, bilirubin levels and advanced test results were assessed at baseline and weekly follow-up.
Findings: Of the infants included, 51.7% were boys while 48.3% were girls. The most common blood type was A Rh (+). There was ABO incompatibility alone in 24 infants (14.2%), Rh incompatibility alone in 6 infants (3.5%) and ABO plus Rh incompatibility in 3 infants (1.2%). In 130 infants, total bilirubin was studied on both week 2 and 3. At week 3, total bilirubin value was ≥10 mg/dl in only 36 infants (27.7%) while it was decreased below 10 mg/dL in 94 infants (72.3%). Urinary tract infection (UTI) was detected in 7 of 38 infants with available tests at week 2. Two of 6 infants with UTI had other clinical signs of UTI. Mean total bilirubin value was 17.9 mg/dL in 5 infants. A significant correlation was found between UTI and vomiting, breastfeeding and feeding pattern (p
Publisher
Acil Tip Uzmanlari Dernegi
Reference20 articles.
1. 1- Piazza AJ, Stoll BJ, Jaundice and hyperbilirubinemia in the newborn. In: Kliegman RM, Geme JS, Berhman RE, Stanton BF (ed), Nelson Textbook of Pediartics, 20th ed, WB Saunders Comp, Philadelphia. 2015:756-65
2. 2- Melton K, Akinbi HT. Neonatal jaundice: strategies to reduce bilirubin – induced complications. Postgraduate Med 1999; 106:167-178.)( Oran O, Gürakan B, Bilirubin metabolizması. Katkı Pediatri Dergisi. 1995; 16:667-
3. 3- National Institute for Health and Clinical Excellence. Neonatal Jaundice. (Clinical Guideline 98). See www.nice.org.uk/CG98 (last checked 1 June 2012
4. 4- Çoban A, Türkmen M, Gürsoy T. Türk Neonatoloji Derneği Yenidoğan Sarılıklarında Yaklaşım, İzlem Ve Tedavi Rehberi 2014.
5. 5- Tyrell M, Hingley S, Giles C, Menakaya JO. Impact of delayed screening for prolonged jaundice in the newborn. Arch Dis Child Fetal Neonatal Ed 2009; 94:F154